Genmab CEO lands USD 6.8m salary in 2021
After three years with results in line with analysts’ expectations, the CEO of Danish biotech company Genmab has received a raise, bringing his 2021 wages to DKK 44.3m (USD 6.8m).
by albert rønning-andersson, translated by daniel pedersen
CEO at Genmab Jan van de Winkel’s wallet has become thicker again this year, following a 2021 in which the Danish biotech company largely lived up to expectations with a revenue of DKK 8.5bn (USD 1.3bn) and an operating profit (EBIT) of DKK 3bn (USD 461m).
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Genmab raises 2022 sales outlook to top USD 1.6bn
For subscribers
Deborah Dunsire beats Novo Nordisk CEO in salary comparison
For subscribers
